IPI is a leader in medical advancement, we use cutting-edge technologies, including computational biology, AI, and high-throughput screening, to identify novel drug candidates. We then use advanced in vitro and in vivo models to assess safety and efficacy, adaptive clinical trial designs, and real-world evidence, to accelerate the development of promising therapies that have the potential to transform lives.

The following table provides an overview of our current research and development ( R&D) pipeline products: